In this month’s EDI Spotlight, Madhav Swaminathan, MD shares how he became involved with a group focused on increasing inclusion of neurodiversity, a disability that he says is often hidden yet deserves more attention in EDI work.

As part of the university's centennial celebration, the Duke Cancer Institute hosted the 2nd annual MaryAnn Black Distinguished Health Equity Symposium in honor of the late MaryAnn Black.

A principal link in the life of this university.” That is how former Duke University President Richard H. Broadhead described Mary Duke Biddle Trent Semans.

Duke University, in collaboration with the University of North Carolina-Chapel Hill and ​​​NC​​ State University, has received a three-year, $3 million grant from the Chan​ ​Zuckerberg Initiative (

Duke University and North Carolina Central University recently received the National Institutes of Health (NIH) Institutional Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) in

Duke University Hospital focuses on an often-overlooked issue in gun violence: creating a path forward for gunshot wound survivors.

An internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality, and clinical research, Dr. Robert Califf now heads the U.S. Food and Drug Administration.

Duke’s chief of pediatric cardiac surgery, Dr. Joseph W. Turek, has built his career on repairing the defective or damaged hearts of the very youngest patients, while continually looking for ways to make their care better.

Regardless of socioeconomic factors and tumor variables, Black women with triple negative breast cancer have a significantly poorer response to chemotherapy than white women, researchers at Duke Cancer Institute report.

In a finding that could help reduce the racial disparity in kidney disease, Duke Health researchers have detailed how two common gene variants among African Americans can cause kidney failure.